This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Gilead Sciences, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Sarah A. Gilmore: Innovator in Immunology
Introduction
Sarah A. Gilmore is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of immunology, particularly through her innovative work on interleukin-2 variant proteins. Her research focuses on enhancing immune responses, which has important implications for the treatment of viral infections and cancer.
Latest Patents
Sarah holds a patent for "Interleukin-2 variant proteins fused to human IgG4 Fc and uses thereof." This patent describes serum half-life extended-IL-2 variant heterodimers that exhibit reduced binding to the IL2Rα (CD25) subunit. The Fc-IL-2v heterodimers provided in her patent are designed for methods that enhance immune responses, particularly in the prevention and treatment of various diseases.
Career Highlights
Sarah A. Gilmore is currently employed at Gilead Sciences, Inc., where she continues to advance her research in immunology. Her work has positioned her as a key figure in the development of therapies aimed at improving patient outcomes in critical health areas.
Collaborations
Throughout her career, Sarah has collaborated with notable colleagues, including Manuel Baca and Hassan Javanbakht. These partnerships have contributed to the success of her research and the development of innovative solutions in the field.
Conclusion
Sarah A. Gilmore is a trailblazer in the field of immunology, with her patented innovations paving the way for advancements in the treatment of viral infections and cancer. Her contributions continue to impact the scientific community and improve health outcomes for patients.